PostEra uses AI for drug discovery and synthesis routes

PostEra, a startup co-founded by Matt and Aaron, has developed a machine learning platform to streamline medicinal chemistry and drug discovery. Their approach uses ML to predict chemical reaction outcomes and design synthesis routes, similar to how Google Translate works and employing search algorithms akin to AlphaGo. The platform allows clients to input a desired molecule, receive a designed synthesis route, and order the compound through PostEra's network of manufacturing partners. Initially focused on general drug discovery, PostEra is now applying its technology to the COVID Moonshot initiative to accelerate the development of treatments for SARS-CoV-2. AI

IMPACT Accelerates drug discovery timelines by applying ML to chemical synthesis and route design.

RANK_REASON The item describes a company's product and approach to drug discovery using ML, not a novel model release or research breakthrough.

Read on HN — machine learning stories →

• Aaron
• AlphaGo
• COVID Moonshot
• Google Translate
• Matt
• PostEra
• SARS-CoV-2 Alpha variant
• University of Cambridge
• University of Oxford

• product
• model release

AI-generated summary · Google Gemini · from 1 sources. How we write summaries →